Serum PCSK9 levels, but not PCSK9 polymorphisms, are associated with CAD risk and lipid profiles in southern Chinese Han population

The Role of PCSK9 Inhibitors in the Treatment of Hypercholesterolemia

(2018) Roshni S. Patel et al.   ANNALS OF PHARMACOTHERAPY

Role of PCSK9 in lipid metabolism and atherosclerosis

(2018) Xiao-Long Lin et al.   BIOMEDICINE & PHARMACOTHERAPY

R46L polymorphism in the PCSK9 gene: Relationship to lipid levels, subclinical vascular disease, and erectile dysfunction

(2018) Jose M. Mostaza et al.   Journal of Clinical Lipidology

DOCK7-ANGPTL3 SNPs and their haplotypes with serum lipid levels and the risk of coronary artery disease and ischemic stroke

(2018) Wei-Jun Li et al.   Lipids in Health and Disease

Temporal trends in secondary prevention in myocardial infarction patients discharged with left ventricular systolic dysfunction in Poland

(2018) Mariusz Gasior et al.   European Journal of Preventive Cardiology

Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome

(2018) Kwi-Hyun Bae et al.   Diabetes & Metabolism Journal

Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke

(2017) Jemma C Hopewell et al.   EUROPEAN HEART JOURNAL

Does Evolocumab, as a PCSK9 Inhibitor, Ameliorate the Lipid Profile in Familial Hypercholesterolemia Patients? A Meta-Analysis of Randomized Controlled Trials

(2017) Seyyed Majid Eslami et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

What is the impact of PCSK9 rs505151 and rs11591147 polymorphisms on serum lipids level and cardiovascular risk: a meta-analysis

(2017) Chengfeng Qiu et al.   Lipids in Health and Disease

The atherogenic index of plasma is a strong and independent predictor for coronary artery disease in the Chinese Han population

(2017) Gaojun Cai et al.   MEDICINE

Gender-and lesion number-dependent difference in “atherogenic index of plasma” in Chinese people with coronary heart disease

(2017) Wei Ni et al.   Scientific Reports

Evaluation of plasma PCSK9 concentrations, transcript of LDL receptor, as well as the total number of monocyte LDL receptors in acute coronary syndrome patients

(2016) Paweł Burchardt et al.   Cardiology Journal

Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk FactorsCLINICAL PERSPECTIVE

(2016) Karin Leander et al.   CIRCULATION

E670G polymorphism of PCSK9 gene of patients with coronary heart disease among Han population in Hainan and three provinces in the northeast of China

(2016) Xi-Min He et al.   Asian Pacific Journal of Tropical Medicine

Associations of Rs3744841 and Rs3744843 Polymorphisms in Endothelial Lipase Gene with Risk of Coronary Artery Disease and Lipid Levels in a Chinese Population

(2016) Gaojun Cai et al.   PLoS One

Both Rare and Common Variants inPCSK9Influence Plasma Low-Density Lipoprotein Cholesterol Level in American Indians

(2015) Ching-Wei Tsai et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Combined PCSK9 and APOE Polymorphisms are Genetic Risk Factors Associated with Elevated Plasma Lipid Levels in a Thai Population

(2015) Nutjaree Jeenduang et al.   LIPIDS

The associations between proprotein convertase subtilisin/kexin type 9 E670G polymorphism and the risk of coronary artery disease and serum lipid levels: a meta-analysis

(2015) Gaojun Cai et al.   Lipids in Health and Disease

Effect of E670G Polymorphism in PCSK9 Gene on the Risk and Severity of Coronary Heart Disease and Ischemic Stroke in a Tunisian Cohort

(2014) Afef Slimani et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Proprotein Convertase Subtilisin/Kexin Type 9 Gene E670G Polymorphism Interacts with Alcohol Consumption to Modulate Serum Lipid Levels

(2013) Lynn Htet Htet Aung et al.   International Journal of Medical Sciences

The association between endothelial lipase −384A/C gene polymorphism and acute coronary syndrome in a Chinese population

(2012) Gaojun Cai et al.   MOLECULAR BIOLOGY REPORTS

The PCSK9 gene E670G polymorphism affects low-density lipoprotein cholesterol levels but is not a risk factor for coronary artery disease in ethnic Chinese in Taiwan

(2009) Lung-An Hsu et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE